- ISBN: 9780123749086 | 0123749085
- Cover: Hardcover
- Copyright: 5/27/2009
Contributors | p. xiii |
Preface | p. xxi |
Volumes in Series | p. xxiii |
Chemokines and Receptors in Disease | p. 1 |
Chemokines in Human Breast Tumor Cells: Modifying Their Expression Levels and Determining Their Effects on the Malignancy Phenotype | p. 3 |
Introduction | p. 4 |
Modifying Chemokine Expression in Breast Tumor Cells | p. 5 |
Establishment of Primary Local Breast Tumors and Pulmonary Metastases | p. 9 |
Acknowledgments | p. 15 |
References | p. 15 |
CCR5 Pharmacology Methodologies and Associated Applications | p. 17 |
Introduction | p. 18 |
CCR5 Signaling Assays and Application to Quantify and Characterize Ligand-Dependent Agonism, Antagonism, and Inverse Agonism | p. 19 |
CCR5-Associated Ligand-Binding Assays | p. 33 |
Surrogate In Vitro Antiviral Assays | p. 38 |
CCR5 Site-Directed Mutagenesis and Ligand Docking Studies | p. 43 |
Non-HIV Indications-Associated Studies, Human CCR5 Knock-In Mice | p. 48 |
References | p. 52 |
CXCR4 and Mobilization of Hematopoietic Precursors | p. 57 |
Introduction | p. 58 |
HSPC Mobilizing Agents that Target the CXCL12/CXCR4 Axis | p. 59 |
Donor Selection for HSPC Mobilization | p. 64 |
Flow Cytometric Enumeration of Mobilized HSPCs | p. 65 |
Dosing and Kinetics of HSPC Mobilization by G-CSF and Plerixafor | p. 66 |
Flow Cytometric Analysis of CXCR4 Expression on Human CD34+ Subsets | p. 69 |
Functional Characterization of Mobilized HSPCs | p. 73 |
Concluding Remarks | p. 80 |
Acknowledgment | p. 80 |
References | p. 80 |
Double-Label Nonradioactive In Situ Hybridization for the Analysis of Chemokine Receptor Expression in the Central Nervous System | p. 91 |
Introduction | p. 92 |
Basic Protocol for ISH (Using Digoxygenin-Labeled Probe) | p. 93 |
Comments | p. 101 |
References | p. 102 |
Expression of Chemokines and Chemokine Receptors in Human Colon Cancer | p. 105 |
Introduction | p. 106 |
Materials and Methods | p. 108 |
Results | p. 110 |
Discussion | p. 117 |
Acknowledgments | p. 119 |
References | p. 119 |
Chemokine Related Proteins from Pathogens | p. 123 |
Kaposi's Sarcoma Virally Encoded, G-Protein-Coupled Receptor: A Paradigm for Paracrine Transformation | p. 125 |
Introduction | p. 127 |
Cloning of vGPCR | p. 128 |
Assaying vGPCR Transforming Activity In Vitro | p. 130 |
vGPCR Transforming Activity In Vivo Using Xenograft Systems | p. 130 |
In Vivo Targeted Infection Using the TVA-RCAS System | p. 131 |
vGPCR-Induced Paracrine Transformation | p. 134 |
Characterization of vGPCR-Induced Molecular Signaling | p. 135 |
Evaluation of Activation of Second-Messenger-Generating Systems | p. 136 |
Activation of Signal-Transducing Protein Kinases and Small GTPases | p. 137 |
Akt Kinase Assay | p. 137 |
vGPCR Stimulated Activation of Rac1-Pulldown Assays | p. 138 |
Western Blotting Using Phospho-Specific Antibodies | p. 140 |
Activation of Transcription Factors | p. 141 |
Global Changes in Gene Expression: Microarray Analysis | p. 141 |
NFkB Luciferase Assays | p. 143 |
NFkB Binding Assays | p. 144 |
Nuclear Translocation of NFkB | p. 146 |
Acknowledgments | p. 147 |
References | p. 147 |
Pharmacological and Biochemical Characterization of Human Cytomegalovirus-Encoded G Protein-Coupled Receptors | p. 151 |
Introduction | p. 152 |
Virally Encoded GPCR Engineering | p. 154 |
vGPCR Expression, Trafficking, and Radioligand Binding | p. 156 |
vGPCR-Induced Signal Transduction | p. 159 |
vGPCR-Induced Oncogenesis | p. 162 |
Generation of Recombinant HCMV Strains by Markerless Bacterial Artificial Chromosome Mutagenesis | p. 165 |
Conclusions | p. 167 |
Acknowledgments | p. 167 |
References | p. 167 |
Identification and Characterization of Virus-Encoded Chemokine Binding Proteins | p. 173 |
Introduction | p. 174 |
Methods for Studying Chemokine-Binding Proteins | p. 175 |
Acknowledgments | p. 189 |
References | p. 189 |
The Chemokine-Binding Protein M3 as a Tool to Understand the Chemokine Network In Vivo | p. 193 |
Introduction | p. 193 |
Generation of Transgenic Mice Expressing M3 in Insulin-Producing b Cells | p. 195 |
M3 Expression in Islets of Langerhans Blocks CCL2-, CCL21-, and CXCL13-Induced Migration of Cells to Islets | p. 198 |
M3 Expression in b Cells Blocks Cellular Infiltration and Prevents Diabetes Development | p. 199 |
Generation of a Conditional Transgenic System for Expression of M3 | p. 202 |
Concluding Remarks | p. 204 |
References | p. 205 |
M-T7: Measuring Chemokine-Modulating Activity | p. 209 |
Introduction | p. 210 |
Protein Expression | p. 213 |
Quantifying the Effects of M-T7 In Vitro and Ex Vivo | p. 216 |
Quantifying the Effects of M-T7 on Vascular Inflammatory Responses in Rodent Vascular Transplant Models | p. 220 |
Preclinical Toxicity Testing | p. 225 |
References | p. 227 |
Atypical and Novel Chemoattractants and Receptors | p. 229 |
Role of the Chemokine Scavenger Receptor D6 in Balancing Inflammation and Immune Activation | p. 231 |
Introduction | p. 232 |
Methods | p. 232 |
Results | p. 235 |
Discussion | p. 236 |
References | p. 241 |
Structure-Function Dissection of D6, an Atypical Scavenger Receptor | p. 245 |
Introduction | p. 246 |
Acknowledgments | p. 260 |
References | p. 260 |
Modeling Small Molecule-Compound Binding to G-Protein-Coupled Receptors | p. 263 |
Introduction | p. 264 |
Similarity and Differences in the Crystal Structures of Class-A GPCRs Solved to Date | p. 265 |
GPCR Modeling Methods | p. 266 |
Computational Methods for Receptor Flexibility and Ligand-Induced Conformational Changes in GPCRs | p. 271 |
Validation of GPCR-Ligand Models | p. 274 |
Conclusions | p. 284 |
References | p. 286 |
Elucidation of Chemerin and Chemokine-Like Receptor-1 Function in Adipocytes by Adenoviral-Mediated shRNA Knockdown of Gene Expression | p. 289 |
Introduction | p. 290 |
The 3T3-L1 Cell Model for Adipogenesis and Adipocyte Metabolism | p. 292 |
RNA Interference | p. 293 |
Methods for Adenoviral shRNA Knockdown of Chemerin and CMKLR1 in 3T3-L1 Cells | p. 297 |
Concluding Remarks | p. 309 |
Acknowledgments | p. 309 |
References | p. 309 |
Chemokine Signaling | p. 313 |
Characterization of Chemokine Receptor CXCR2 Interacting Proteins Using a Proteomics Approach to Define the CXCR2 "Chemosynapse" | p. 315 |
Introduction | p. 316 |
Validation of the Interaction of Novel Proteins with CXCR2 | p. 320 |
Mutational Analysis of Residues at Interactive Interface of CXCR2 and CXCR2-Binding Proteins | p. 324 |
Radioactive Phosphorylation of CXCR2 Interacting Proteins | p. 325 |
Chemotaxis Assay | p. 326 |
Conclusions | p. 329 |
Acknowledgments | p. 329 |
References | p. 329 |
Phosphoproteomic Analysis of Chemokine Signaling Networks | p. 331 |
Introduction | p. 332 |
Methods | p. 334 |
Summary | p. 343 |
Acknowledgments | p. 344 |
References | p. 345 |
Monitoring NF-kB Mediated Chemokine Transcription in Tumorigenesis | p. 347 |
Introduction | p. 348 |
Development of NF-kB Reporter Model for Tumors | p. 348 |
Bioluminescent Imaging of Intratumor Signaling of Anesthetized Mice | p. 349 |
Cell-Based Assays for Kinase and Transcriptional Activity In Vitro | p. 352 |
Peripheral Spying of Intratumoral Signaling of Conscious Mice | p. 353 |
Acknowledgments | p. 354 |
References | p. 354 |
Analysis of Chemokine Receptor Endocytosis and Intracellular Trafficking | p. 357 |
Introduction | p. 358 |
Receptor Detection | p. 360 |
Cells | p. 362 |
Monitoring Receptor Endocytosis | p. 364 |
Monitoring Receptor Recycling | p. 366 |
Monitoring Receptor Degradation | p. 368 |
Electron Microscopy Analysis of Receptor Internalization | p. 371 |
Acknowledgments | p. 375 |
References | p. 375 |
Measuring the Proximity of T-Lymphocyte CXCR4 and TCR by Fluorescence Resonance Energy Transfer (FRET) | p. 379 |
Introduction | p. 380 |
Assaying CXCR4-TCR Proximity via the PE/APC mAb FRET Approach | p. 386 |
Assaying CXCR4-TCR Proximity via the CFP/YFP Fusion Protein Approach | p. 392 |
Concluding Remarks | p. 396 |
References | p. 396 |
Expression of CXCR4, a G-Protein-Coupled Receptor for CXCL12 in Yeast: Identification of New-Generation Inverse Agonists | p. 399 |
Introduction | p. 400 |
Methods and Discussion | p. 402 |
Summary | p. 408 |
References | p. 410 |
Ubiquitination of Chemokine Receptors | p. 413 |
Introduction | p. 414 |
Cell Culture and Transfections | p. 416 |
Agonist Treatment and Ubiquitination Assay | p. 417 |
E3 Ubiquitin Ligase AIP4 Mediates Ubiquitination of CXCR4 | p. 419 |
References | p. 421 |
Author Index | p. 423 |
Subject Index | p. 451 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.